pmcc logo sml


 Here are the staff publications for September 2023.

Compiled by the Health Sciences Library (RMH, RWH, PMCC & Victorian Mental Health) 9th October 2023.


  1. Barraclough A, England JT, Villa D, Wight J, Hapgood G, Conn J, Doo NW, Li EW, Gilbertson M, Shaw B, Bishton MJ, Saeed M, Ratnasingam S, Abeyakoon C, Chong G, Wai SH, Ku M, Lee HP, Fleming K, Tam C, Douglas G, Cheah CY, Ng ZY, Rolfe T, Mills AK, Hamad N, Cashman H, Gleeson M, Narayana M, Hawkes EA. Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance. Haematologica 2023;108:2444-53.
  2. Bhar S, Davison TE, Schofield P, Quinn S, Ratcliffe J, Waloszek JM, Dunkerley S, Silver M, Linossier J, Koder D, Collins R, Milte R. Study protocol for ELders AT Ease (ELATE): a cluster randomised controlled trial of cognitive behaviour therapy to reduce depressive symptoms in aged care residents. BMC Geriatr 2023;23:555.
  3. Brennen R, Soh SE, Denehy L, Lin KY, Jobling T, McNally OM, Hyde S, Kruger J, Frawley H. Pelvic floor muscle training delivered via telehealth to treat urinary and/or faecal incontinence after gynaecological cancer surgery: a single cohort feasibility study. Support Care Cancer 2023;31:589.
  4. Caramia F, Speed TP, Shen H, Haupt Y, Haupt S. Establishing the Link between X-Chromosome Aberrations and TP53 Status, with Breast Cancer Patient Outcomes. Cells 2023;12.
  5. Copaescu AM, Vogrin S, James F, Chua KYL, Rose MT, De Luca J, Waldron J, Awad A, Godsell J, Mitri E, Lambros B, Douglas A, Youcef Khoudja R, Isabwe GAC, Genest G, Fein M, Radojicic C, Collier A, Lugar P, Stone C, Ben-Shoshan M, Turner NA, Holmes NE, Phillips EJ, Trubiano JA. Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial. JAMA Intern Med 2023;183:944-52.
  6. Corrente C, Satkumaran S, Segal A, Butters C, Fernandez C, Babl FE, Orme LM, Thursky K, Haeusler GM. Evaluating the accuracy and efficacy of an electronic medical record alert to identify paediatric patients with low-risk febrile neutropenia. Int J Med Inform 2023;178:105205.
  7. Cui W, Rocconi RP, Thota R, Anderson RA, Bruinooge SS, Comstock IA, Denduluri N, Gassman A, Gralow J, Hutt KJ, Amiri-Kordestani L, Lambertini M, Leighton J, Lu KH, Mostoufi-Moab S, Pollastro T, Pradhan S, Saber H, Schenkel C, Spratt D, Wedam S, Phillips KA. Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement. Lancet Oncol 2023;24:e415-e23.
  8. Davidson AL, Dressel U, Norris S, Canson DM, Glubb DM, Fortuno C, Hollway GE, Parsons MT, Vidgen ME, Holmes O, Koufariotis LT, Lakis V, Leonard C, Wood S, Xu Q, McCart Reed AE, Pickett HA, Al-Shinnag MK, Austin RL, Burke J, Cops EJ, Nichols CB, Goodwin A, Harris MT, Higgins MJ, Ip EL, Kiraly-Borri C, Lau C, Mansour JL, Millward MW, Monnik MJ, Pachter NS, Ragunathan A, Susman RD, Townshend SL, Trainer AH, Troth SL, Tucker KM, Wallis MJ, Walsh M, Williams RA, Winship IM, Newell F, Tudini E, Pearson JV, Poplawski NK, Mar Fan HG, James PA, Spurdle AB, Waddell N, Ward RL. The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study. Genome Med 2023;15:74.
  9. Fernando M, Anton A, Weickhardt A, Azad AA, Uccellini A, Brown S, Wong S, Parente P, Shapiro J, Liow E, Torres J, Goh J, Parnis F, Steer C, Warren M, Gibbs P, Tran B. Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort. J Geriatr Oncol 2023;14:101621.
  10. Garnish SE, Martin KR, Kauppi M, Jackson VE, Ambrose R, Eng VV, Chiou S, Meng Y, Frank D, Tovey Crutchfield EC, Patel KM, Jacobsen AV, Atkin-Smith GK, Di Rago L, Doerflinger M, Horne CR, Hall C, Young SN, Cook M, Athanasopoulos V, Vinuesa CG, Lawlor KE, Wicks IP, Ebert G, Ng AP, Slade CA, Pearson JS, Samson AL, Silke J, Murphy JM, Hildebrand JM. A common human MLKL polymorphism confers resistance to negative regulation by phosphorylation. Nat Commun 2023;14:6046.
  11. Gartrell R, Qiao J, Kiss N, Faragher I, Chan S, Baird PN, Yeung JM. Can sarcopenia predict survival in locally advanced rectal cancer patients? ANZ J Surg 2023;93:2166-71.
  12. Goel S, Chandarlapaty S. Emerging Therapies for Breast Cancer. Cold Spring Harb Perspect Med 2023;13.
  13. Guccione L, Gough K, Drosdowsky A, Price T, Pavlakis N, Wyld D, Ransom D, Michael M, Schofield P. The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosis. Support Care Cancer 2023;31:577.
  14. Gupta R, Selinger CI, Ashford B, Chua MST, Clark JR, Damian DL, Jackett LA, James C, Johnson S, Ladwa R, Lambie D, McKenzie C, Tan ST, Scolyer RA. Implementing structured pathology reporting protocol for non-melanocytic skin cancers: practical considerations. Pathology 2023;55:743-59.
  15. Hall VG, Sim BZ, Lim C, Hocking C, Teo T, Runnegar N, Boan P, Heath CH, Rainey N, Lyle M, Steer C, Liu E, Doig C, Drummond K, Charles PGP, See K, Lim LL, Shum O, Bak N, McLachlan SA, Singh KP, Laundy N, Gallagher J, Stewart M, Saunders NR, Klimevski E, Demajo J, Reynolds G, Thursky KA, Worth LJ, Spelman T, Yong MK, Slavin MA, Teh BW. COVID-19 infection among patients with cancer in Australia from 2020 to 2022: a national multicentre cohort study. Lancet Reg Health West Pac 2023;38:100824.
  16. Hanson H, Astiazaran-Symonds E, Amendola LM, Balmana J, Foulkes WD, James P, Klugman S, Ngeow J, Schmutzler R, Voian N, Wick MJ, Pal T, Tischkowitz M, Stewart DR, Practices AP, Guidelines Committee. Electronic address dan. Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2023;25:100870.
  17. Hegi-Johnson F, Rudd SE, Wichmann CW, Akhurst T, Roselt P, Sursock S, Trinh J, John T, Devereux L, Donnelly PS, Hicks RJ, Scott AM, Steinfort D, Fox S, Blyth B, Parakh S, Hanna GG, Callahan J, Burbury K, MacManus M. PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study. Int J Radiat Oncol Biol Phys 2023;117:675-82.
  18. Henson CE, Abou-Foul AK, Morton DJ, McDowell L, Baliga S, Bates J, Lee A, Bonomo P, Szturz P, Nankivell P, Huang SH, Lydiatt WM, O'Sullivan B, Mehanna H. Diagnostic challenges and prognostic implications of extranodal extension in head and neck cancer: a state of the art review and gap analysis. Front Oncol 2023;13:1263347.
  19. Hoe HJ, Balasubramanian A, John T. LASERing FLAURAL Arrangements in Asian EGFR Subsets. J Thorac Oncol 2023;18:1261-4.
  20. Jones TL, Edbrooke L, Rawstorn JC, Hayes SC, Maddison R, Denehy L, Short CE. Self-efficacy, motivation, and habits: psychological correlates of exercise among women with breast cancer. Support Care Cancer 2023;31:584.
  21. Kashyap R, Neef P, Sivaratnam D, Better N. Correlation of current myocardial perfusion imaging and previous coronary angiography to avert the need for repeat intervention - A case report. J Med Imaging Radiat Sci 2023;54:572-5.
  22. Keogh C, O'Sullivan NJ, Temperley HC, Flood MP, Ting P, Walsh C, Waters P, Ryan É J, Conneely JB, Edmundson A, Larkin JO, McCormick JJ, Mehigan BJ, Taylor D, Warrier S, McCormick PH, Soucisse ML, Harris CA, Heriot AG, Kelly ME. Redo Pelvic Surgery and Combined Metastectomy for Locally Recurrent Rectal Cancer with Known Oligometastatic Disease: A Multicentre Review. Cancers (Basel) 2023;15.
  23. Khan A, Beaumont A, Laing E, Guerra G, Jain A, Warrier S, Heriot A. Parenteral nutrition after cytoreductive surgery for peritoneal malignancy: Should it be administered routinely? Clin Nutr ESPEN 2023;57:487-93.
  24. Kwok C, Nolan M. Cardiotoxicity of anti-cancer drugs: cellular mechanisms and clinical implications. Front Cardiovasc Med 2023;10:1150569.
  25. Lai-Kwon J, Inderjeeth AJ, Lisy K, Sandhu S, Rutherford C, Jefford M. Corrigendum to 'Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review [European Journal of Cancer 184 (2023) 83-105]. Eur J Cancer 2023;190:112937.
  26. Lasocki A, Stuckey SL, Caspersz L, Xie J, McArthur GA. Prospective Comparison of T1-SPACE and MPRAGE for the Identification of Intrinsic T1 Hyperintensity in Patients with Intracranial Melanoma Metastases. AJNR Am J Neuroradiol 2023;44:1039-44.
  27. Lau RC, Anderson PJ, Wiley JF, Huang D, Surjatin F, McIntosh P, Gathercole S, Spencer-Smith M. Working Memory Training for Children Using the Adaptive, Self-Select, and Stepwise Approaches to Setting the Difficulty Level of Training Activities: Protocol for a Randomized Controlled Trial. JMIR Res Protoc 2023;12:e47496.
  28. Loft M, Shapiro J, Lee M, Wong R, Tie J, Kosmider S, Wong V, Jalali A, Lee B, Ananda SS, Gibbs P. Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancer. Intern Med J 2023;53:1610-7.
  29. Lonski P, MacManus M, Campbell BA, Wheeler G, Ungureanu E, Kron T. Assessment of lung doses in patients undergoing total body irradiation for haematological malignancies with and without lung shielding. J Med Imaging Radiat Oncol 2023;67:684-90.
  30. Machiels M, Oulkadi R, Tramm T, Stecklein SR, Somaiah N, De Caluwé A, Klein J, Tran WT, Salgado R. Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers. Breast 2023;71:13-21.
  31. Marco DJT, McMillan-Drendel E, Philip JAM, Williamson T, Le B. Establishment of the first Australian public and health-professional palliative care advice service: exploring caller needs and gaps in care. Aust Health Rev 2023;47:569-73.
  32. Marston C, Morgan DD, Philip J, Agar MR. Experience and acceptability of a carer-focussed intervention in acute oncology settings: A qualitative study of people with advanced cancer and their carers. Aust Occup Ther J 2023;70:570-80.
  33. Mattox AK, Douville C, Wang Y, Popoli M, Ptak J, Silliman N, Dobbyn L, Schaefer J, Lu S, Pearlman AH, Cohen JD, Tie J, Gibbs P, Lahouel K, Bettegowda C, Hruban RH, Tomasetti C, Jiang P, Chan KCA, Lo YMD, Papadopoulos N, Kinzler KW, Vogelstein B. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer. Cancer Discov 2023;13:2166-79.
  34. McWilliam A, Palma G, Abravan A, Acosta O, Appelt A, Aznar M, Monti S, Onjukka E, Panettieri V, Placidi L, Rancati T, Vasquez Osorio E, Witte M, Cella L. Voxel-based analysis: Roadmap for clinical translation. Radiother Oncol 2023;188:109868.
  35. Moore J, Hamad N, Gottlieb D, Bajel A, Ritchie D, Yeung D, Greenwood M, Purtill D, Tran S, Solterbeck A, Aarons D, Kwan J. Early cessation of calcineurin inhibitors is feasible post-haploidentical blood stem cell transplant: the ANZHIT 1 study. Blood Adv 2023;7:5554-65.
  36. Munzone E, Regan MM, Cinieri S, Montagna E, Orlando L, Shi R, Campadelli E, Gianni L, Palleschi M, Petrelli F, Bengala C, Generali D, Collova E, Puglisi F, Cretella E, Zamagni C, Chini C, Ruepp B, Loi S, Colleoni M, International Breast Cancer Study G. Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial. JAMA Oncol 2023;9:1267-72.
  37. Odutola MK, van Leeuwen MT, Bruinsma FJ, Benke G, Turner MC, Trotman J, Turner J, Seymour JF, Prince HM, Milliken ST, Tiley C, Hertzberg M, Roncolato F, Opat S, Lindeman R, Verner E, Underhill CR, Cardis E, Giles G, Vajdic CM. Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case-control study. Occup Environ Med 2023;80:599-602.
  38. Philip J, Le B, La Brooy C, Olver I, Kerridge I, Komesaroff P. Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years? Curr Treat Options Oncol 2023;24:1365-6.
  39. Revel-Vilk S, Mansfield R, Feder-Krengel N, Machtiger-Azoulay N, Kuter D, Szer J, Rosenbaum H, Ferreira DC, Ruhrman-Shahar N, Wajnrajch M, Zimran A. Real-World Experiences with Taliglucerase Alfa Home Infusions for Patients with Gaucher Disease: A Global Cohort Study. J Clin Med 2023;12.
  40. Reynolds GK, Sim B, Spelman T, Thomas A, Longhitano A, Anderson MA, Thursky K, Slavin M, Teh BW. Infections in haematology patients treated with CAR-T therapies: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2023;192:104134.
  41. Salgado R, AbdulJabbar K. Artificial intelligence biomarkers for digital oncology: a case study of tumor-infiltrating lymphocytes in melanoma. EBioMedicine 2023;96:104796.
  42. Smith HG, Schlesinger NH, Qvortrup C, Chiranth D, Lundon D, Ben-Yaacov A, Caballero C, Suppan I, Kok JH, Holmberg CJ, Mohan H, Montagna G, Santrac N, Sayyed R, Schrage Y, Sgarbura O, Ceelen W, Lorenzon L, Brandl A. Variations in the definition and perceived importance of positive resection margins in patients with colorectal cancer - an EYSAC international survey. Eur J Surg Oncol 2023;49:107072.
  43. Smith S, Sapkaroski D, Brand M, Tran A, Zalcberg J, Stirling RG. Mapping the clinical care pathways for advanced stage non-small cell lung cancer patients in Victoria: A retrospective cohort study of supportive and palliative care. Nurs Health Sci 2023;25:411-23.
  44. Tam CS, Muñoz JL, Seymour JF, Opat S. Correction: Zanubrutinib: past, present, and future. Blood Cancer J 2023;13:154.
  45. Tam CS, Muñoz JL, Seymour JF, Opat S. Zanubrutinib: past, present, and future. Blood Cancer J 2023;13:141.
  46. Terriou L, Lee JW, Forsyth C, Griffin M, Szer J, Röth A, Gustovic P, Metzger J, Patel AS, Patriquin CJ. Long-term effectiveness of eculizumab: Data from the International PNH Registry. Eur J Haematol 2023;111:796-804.
  47. Tio SY, Chen SC, Hamilton K, Heath CH, Pradhan A, Morris AJ, Korman TM, Morrissey O, Halliday CL, Kidd S, Spelman T, Brell N, McMullan B, Clark JE, Mitsakos K, Hardiman RP, Williams P, Campbell AJ, Beardsley J, Van Hal S, Yong MK, Worth LJ, Slavin MA. Invasive aspergillosis in adult patients in Australia and New Zealand: 2017-2020. Lancet Reg Health West Pac 2023;40:100888.
  48. Todio E, Schofield P, Sharp J. A Qualitative Study of Men's Experiences Using Navigate: A Localized Prostate Cancer Treatment Decision Aid. MDM Policy Pract 2023;8:23814683231198003.
  49. Vargas C, Haeusler GM, Slavin MA, Babl FE, Mechinaud F, Phillips R, Thursky K, Lourenco RA, Australian PSG. An analysis of the resource use and costs of febrile neutropenia events in pediatric cancer patients in Australia. Pediatr Blood Cancer 2023;70:e30633.
  50. Verma S, Quin N, Astbury L, Wellecke C, Wiley JF, Davey M, Rajaratnam SMW, Bei B. Treating postpartum insomnia: a three arm randomised controlled trial of cognitive behavioural therapy and light dark therapy. Psychol Med 2023;53:5459-69.
  51. Welarathna S, Velautham S, Sarasanandarajah S. Towards the establishment of national diagnostic reference levels for chest x-ray examinations in Sri Lanka: a multi-centric study. J Radiol Prot 2023;43.
  52. Zaorsky NG, Louie AV, Siva S. Radiation Therapy for Renal Cell Carcinoma. Int J Radiat Oncol Biol Phys 2023;117:523-5.

Contact Details and Hours

(03) 9138 0580
(03) 9342 8615
M - F: 8:30am - 5pm

Library Manager

Susan Monaghan

Health Sciences Library

Royal Melbourne Hospital – City Campus

Ground floor - North

Grattan Street


Learning Resource Centre

Level 7A, Peter MacCallum Cancer Centre

305 Grattan Street